Home > Back to Publisher > Report Information

Mexico Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Global Markets Direct
September 28, 2009
57 Pages - SKU: GMD2469439

Abstract Table of Contents Search inside this report Related Reports

Countries covered: Mexico

Mexico Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Mexico drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in Mexico

Scope

The report provides information on the drug delivery devices market in Mexico.
Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
Total revenues, products sold, end users, and average pricing.
Market shares of all the key competitors such as AstraZeneca International plc, GlaxoSmithKline plc, Baxter International Inc., Novartis AG, and Boehringer Ingelheim GmbH.
Key pipeline products that are set to shape the market, broken down by sector.
Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
Key mergers and acquisitions, partnerships, private equity investments and IPOs.
Customer, hospitals and physicians data.

Reasons to buy

Gain a strong understanding of the drug delivery devices market in Mexico.
Evaluate and compare the attractiveness of the market in the country.
Identify growth segments and opportunities in each industry sector within the country.
Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
Analyze the competitiveness of the market in the country and identify hotspots.
Develop strategies based on the latest product, brand, expansion and research and development news in the country.
Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table of Contents: 1.1 List of Tables; 1.2 List of Figures
2 Introduction: 2.1 What Is This Report About?
3 Definitions of Markets Covered in This Report: 3.1 Drug delivery devices; 3.2 Inhalation Systems; 3.3 Infusion Systems
4 Healthcare Sector Review: 4.1 Healthcare Expenditure
5 Regulation System: 5.1 Device Classification; 5.2 Registration Process; 5.3 Labeling Requirements; 5.4 Import Documentation
6 Pricing and Reimbursement
7 Distribution Structure
8 Drug Delivery Devices In Mexico: 8.1 Drug Delivery Devices, Mexico, Overall Revenue ($ mn), 2000-2015; 8.2 Drug Delivery Devices, Mexico, Category Volume (Units), 2000-2015; 8.3 Drug Delivery Devices, Mexico, Company Share (2007-2008)
9 Infusion Systems In Mexico: 9.1 Infusion Systems Overall Revenue (2000-2015); 9.2 Infusion Systems Overall Volume (2000-2015); 9.3 Infusion Systems Average Price (2000-2015); 9.4 Infusion Systems Distribution Share (2007-2008); 9.5 Infusion Systems, Mexico, Company Share (2007-2008)
10 Inhalation Systems In Mexico: 10.1 Inhalation Systems Overall Revenue (2000-2015); 10.2 Inhalation Systems Overall Volume (2000-2015); 10.3 Inhalation Systems Average Price (2000-2015); 10.4 Inhalation Systems Distribution Share (2007-2008); 10.5 Inhalation Systems, Mexico, Company Share (2007-2008)
11 Overview of Key Companies in Mexico Drug Delivery Devices Market: 11.1 AstraZeneca PLC; 11.2 Boehringer Ingelheim GmbH; 11.3 Baxter International Inc.; 11.4 Novartis AG; 11.5 Terumo Corporation; 11.6 Cardinal Health, Inc.; 11.7 GlaxoSmithKline plc; 11.8 B. Braun Melsungen AG; 11.9 Smiths Medical; 11.10 Fresenius Kabi AG; 11.11 Consort Medical plc; 11.12 Hospira, Inc.
12 Appendix: 12.1 Global Markets Direct Research Methodology; 12.2 Secondary Research; 12.3 Primary Research; 12.4 Models; 12.5 Forecasts; 12.6 Expert Panel Validation; 12.7 Currency Conversion; 12.8 Contact Us; 12.9 Disclaimer
1.1 List of Tables: Table 1: Healthcare Expenditure in Mexico, 2000 - 2007; Table 2: Drug Delivery Devices, Mexico, Overall Revenue ($ mn), 2000-2015; Table 3: Drug Delivery Devices, Mexico, Cross-Category Analysis, 2000-2015; Table 4: Drug Delivery Devices, Mexico, Overall Revenue ($ mn), Historic, 2000-2008; Table 5: Drug Delivery Devices, Mexico, Overall Revenue ($ mn), Forecast, 2008-2015; Table 6: Drug Delivery Devices, Mexico, Category Volume (Units), 2000-2015; Table 7: Drug Delivery Devices, Mexico, Category Volume (Units), Historic, 2000-2008; Table 8: Drug Delivery Devices, Mexico, Category Volume (Units), Forecast, 2008-2015; Table 9: Drug Delivery Devices, Mexico, Company Share by Revenue ($ mn), 2007-2008; Table 10: Infusion Systems, Mexico, Revenue ($ mn) by Segment, Historic, 2000-2008; Table 11: Infusion Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 2008-2015; Table 12: Infusion Systems, Mexico, Volume (Units) by Segment, Historic, 2000-2008; Table 13: Infusion Systems, Mexico, Volume (Units) by Segment, Forecast, 2008-2015; Table 14: Infusion Systems, Mexico, Average Price ($), Historic, 2000-2008; Table 15: Infusion Systems, Mexico, Average Price ($), Forecast, 2008-2015; Table 16: Infusion Systems, Mexico, Distribution Share by Revenue ($mn), 2007-2008; Table 17: Infusion Systems, Mexico, Company Share by Revenue ($ mn), 2007-2008; Table 18: Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Historic, 2000-2008; Table 19: Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 2008-2015; Table 20: Inhalation Systems, Mexico, Volume (Units) by Segment, Historic, 2000-2008; Table 21: Inhalation Systems, Mexico, Volume (Units) by Segment, Forecast, 2008-2015; Table 22: Inhalation Systems, Mexico, Average Price ($), Historic, 2000-2008; Table 23: Inhalation Systems, Mexico, Average Price ($), Forecast, 2008-2015; Table 24: Inhalation Systems, Mexico, Distribution Share by Revenue ($mn), 2007-2008; Table 25: Inhalation Systems, Mexico, Company Share by Revenue ($ mn), 2007-2008; Table 26: Terumo Corporation Pipeline Products by Equipment Type; Table 27: Terumo Corporation Pipeline Products By Development Stage; Table 28: Terumo Corporation Pipeline Products By Therapy Area; Table 29: Terumo Corporation Pipeline Products By Clinical Trials; Table 30: Terumo Corporation Pipeline Products By News Summary; Table 31: Bespak plc Pipeline Products by Equipment Type; Table 32: Bespak plc Pipeline Products By Development Stage; Table 33: Bespak plc Pipeline Products By Therapy Area; Table 34: USD to Local Currency, Average Exchange Rate 2008
1.2 List of Figures: Figure 1: Total Healthcare Expenditure in Mexico, 2000 - 2007; Figure 2: Government and Private Healthcare Expenditure in Mexico, 2007; Figure 3 Drug Delivery Devices, Mexico, Overall Revenue ($ mn), 2000-2015; Figure 4 Drug Delivery Devices, Mexico, Cross-Category Analysis, 2000-2015; Figure 5 Drug Delivery Devices, Mexico, Overall Revenue ($ mn), Historic, 2000-2008; Figure 6 Drug Delivery Devices, Mexico, Overall Revenue ($ mn), Forecast, 2008-2015; Figure 7 Drug Delivery Devices, Mexico, Category Volume (Units), 2000-2015; Figure 8 Drug Delivery Devices, Mexico, Category Volume (Units), Historic, 2000-2008; Figure 9 Drug Delivery Devices, Mexico, Category Volume (Units), Forecast, 2008-2015; Figure 10 Drug Delivery Devices, Mexico, Company Share (%), 2008; Figure 11 Infusion Systems, Mexico, Revenue ($ mn) by Segment, Historic, 2000-2008; Figure 12 Infusion Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 2008-2015; Figure 13 Infusion Systems, Mexico, Company Share (%), 2008; Figure 14 Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Historic, 2000-2008; Figure 15 Inhalation Systems, Mexico, Revenue ($ mn) by Segment, Forecast, 2008-2015; Figure 16 Inhalation Systems, Mexico, Volume (Units) by Segment, Historic, 2000-2008; Figure 17 Inhalation Systems, Mexico, Volume (Units) by Segment, Forecast, 2008-2015; Figure 18 Inhalation Systems, Mexico, Company Share (%), 2008; Figure 19 Global Markets Direct Methodology

More Mexico Reports

Spirits – Mexico – a snapshot (2011) by Mintel - Snapshots
Spirits in Mexico by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2011. This market covers all ...

D&B Country RiskLine Report: Mexico by Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...

D&B Country Report: Mexico by Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...

Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLine
Datamonitor's Soft Drinks: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering ...

Chemicals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide by MarketLine
Datamonitor's Chemicals: Advanced Emerging Markets (Brazil, Hungary, Mexico, Poland, South Africa, Taiwan) Industry Guide is an essential resource for top-level data and analysis covering the ...

See all reports like this >>

Mexico Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Share this report

Other tasks

Research Assistance

Related Markets

Drug Delivery Reports

Free Alert Me service